These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12180235)

  • 1. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India.
    Kumar R; Mukherjee M; Bhandari M; Kumar A; Sidhu H; Mittal RD
    Eur Urol; 2002 Mar; 41(3):318-22. PubMed ID: 12180235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis.
    Kwak C; Kim HK; Kim EC; Choi MS; Kim HH
    Eur Urol; 2003 Oct; 44(4):475-81. PubMed ID: 14499684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
    Siener R; Bangen U; Sidhu H; Hönow R; von Unruh G; Hesse A
    Kidney Int; 2013 Jun; 83(6):1144-9. PubMed ID: 23536130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation.
    Mittal RD; Kumar R; Mittal B; Prasad R; Bhandari M
    Med Princ Pract; 2003; 12(4):208-13. PubMed ID: 12966191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation.
    Kumar R; Ghoshal UC; Singh G; Mittal RD
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1403-9. PubMed ID: 15610315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis.
    Mittal RD; Kumar R
    J Endourol; 2004 Jun; 18(5):418-24. PubMed ID: 15253809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis.
    Batislam E; Yilmaz E; Yuvanc E; Kisa O; Kisa U
    Urol Res; 2012 Oct; 40(5):455-60. PubMed ID: 22215293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract.
    Mittal RD; Kumar R; Bid HK; Mittal B
    J Endourol; 2005; 19(1):102-6. PubMed ID: 15735393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.
    Kaufman DW; Kelly JP; Curhan GC; Anderson TE; Dretler SP; Preminger GM; Cave DR
    J Am Soc Nephrol; 2008 Jun; 19(6):1197-203. PubMed ID: 18322162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.
    Gnanandarajah JS; Abrahante JE; Lulich JP; Murtaugh MP
    Urol Res; 2012 Oct; 40(5):467-73. PubMed ID: 22223029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
    Miller AW; Choy D; Penniston KL; Lange D
    Kidney Int; 2019 Jul; 96(1):180-188. PubMed ID: 31130222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal colonization with Oxalobacter formigenes and its relation to urinary oxalate excretion in pediatric patients with idiopathic calcium urolithiasis.
    Sikora P; Niedźwiadek J; Mazur E; Paluch-Oleś J; Zajaczkowska M; Kozioł-Montewka M
    Arch Med Res; 2009 Jul; 40(5):369-73. PubMed ID: 19766900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of Oxalobacter formigenes and oxalate in stool samples.
    Prokopovich S; Knight J; Assimos DG; Holmes RP
    J Urol; 2007 Nov; 178(5):2186-90. PubMed ID: 17870112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
    Vaidyanathan S; von Unruh GE; Watson ID; Laube N; Willets S; Soni BL
    ScientificWorldJournal; 2006 Apr; 6():2403-10. PubMed ID: 17619709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion.
    Jiang J; Knight J; Easter LH; Neiberg R; Holmes RP; Assimos DG
    J Urol; 2011 Jul; 186(1):135-9. PubMed ID: 21575973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria.
    Sidhu H; Hoppe B; Hesse A; Tenbrock K; Brömme S; Rietschel E; Peck AB
    Lancet; 1998 Sep; 352(9133):1026-9. PubMed ID: 9759746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.